Featured Research

from universities, journals, and other organizations

Novel Anti-inflammatory Molecules Of Microbial Origin

Date:
September 8, 2009
Source:
CNRS (Délégation Paris Michel-Ange)
Summary:
By studying the mycobacteria that cause tuberculosis, molecules with anti-inflammatory properties have been identified by researchers. These molecules, as well as several new analogs, have now been synthesized. In a new study, researchers report the anti-inflammatory activity of these molecules.

By studying the mycobacteria that cause tuberculosis, molecules with anti-inflammatory properties have been identified by the team led by Valérie Quesniaux in the Laboratoire Immunologie et Embryologie Moléculaires, working in collaboration with the Institut de Chimie Organique et Analytique (both based in the University of Orléans/CNRS). These molecules, as well as several new analogs, have been synthesized. Their anti-inflammatory activity has been confirmed, improved and demonstrated in the mouse, as reported in The Journal of Biological Chemistry on August 28, 2009.

Related Articles


The mycobacteria that cause tuberculosis (Mycobacterium tuberculosis) can remain silent for many years in man, thus eluding surveillance by the immune system. In 90% of individuals, the infection is controlled but not eradicated, and the mycobacterium can sometimes survive for several decades. Mycobacterium tuberculosis produces several complex proteins and glycolipids (a combination of sugars and lipids) that are capable of modulating the immune response.

Valérie Quesniaux's team has focused on the interactions between the mycobacterium and its host at the molecular scale, and on the resulting immune mechanisms. On the cell wall of the mycobacteria, the scientists identified low molecular mass glycolipids with very interesting anti-inflammatory properties, the PIM (Phosphatidyl Inositol Mannosides). They synthesized these PIM and reproduced their anti-inflammatory properties.

The team then turned to the synthesis of novel, analog molecules, thus considerably simplifying their synthesis. And indeed, the first example of this new family proved to be even more active than the natural or synthetic molecules tested hitherto. During their study, the researchers demonstrated the enhanced anti-inflammatory activity of these novel PIM molecules both in vitro and in an in vivo model of pulmonary inflammation.

Two patents have been filed in the context of this research. The use of such immunomodulating molecules of microbial origin for therapeutic purposes is seeing considerable growth. These new molecules could be used in the treatment of severe, chronic, inflammatory diseases such as rheumatoid arthritis, Crohn's disease or psoriasis.


Story Source:

The above story is based on materials provided by CNRS (Délégation Paris Michel-Ange). Note: Materials may be edited for content and length.


Journal Reference:

  1. Emilie Doz, Stéphanie Rose, Nathalie Court, Sophie Front, Virginie Vasseur, Sabine Charron, Martine Gilleron, Germain Puzo, Isabelle Fremaux, Yves Delneste, François Erard, Bernhard Ryffel, Olivier R. Martin and Valerie F. J. Quesniaux. Mycobacterial Phosphatidylinositol Mannosides Negatively Regulate Host Toll-like Receptor 4, MyD88-dependent Proinflammatory Cytokines, and TRIF-dependent Co-stimulatory Molecule Expression. Journal of Biological Chemistry, 2009; 284 (35): 23187 DOI: 10.1074/jbc.M109.037846

Cite This Page:

CNRS (Délégation Paris Michel-Ange). "Novel Anti-inflammatory Molecules Of Microbial Origin." ScienceDaily. ScienceDaily, 8 September 2009. <www.sciencedaily.com/releases/2009/09/090902122525.htm>.
CNRS (Délégation Paris Michel-Ange). (2009, September 8). Novel Anti-inflammatory Molecules Of Microbial Origin. ScienceDaily. Retrieved March 30, 2015 from www.sciencedaily.com/releases/2009/09/090902122525.htm
CNRS (Délégation Paris Michel-Ange). "Novel Anti-inflammatory Molecules Of Microbial Origin." ScienceDaily. www.sciencedaily.com/releases/2009/09/090902122525.htm (accessed March 30, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, March 30, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) — A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
Sierra Leone in Ebola Lockdown

Sierra Leone in Ebola Lockdown

Reuters - News Video Online (Mar. 27, 2015) — Millions of people in Sierra Leone are urged to stay at home in a three-day lockdown to help end the country&apos;s Ebola outbreak. Paul Chapman reports. Video provided by Reuters
Powered by NewsLook.com
WH Plan to Fight Antibiotic-Resistant Germs

WH Plan to Fight Antibiotic-Resistant Germs

AP (Mar. 27, 2015) — The White House on Friday announced a five-year plan to fight the threat posed by antibiotic-resistant bacteria amid fears that once-treatable germs could become deadly. (March 27) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins